Hair cloning has been a success for researchers in the U.S who claim an FDA-cleared wound healing powder allowed them to create a technique that multiplies the number of hair follicles in an area that had been dormant, a discovery which could prove invaluable for hair loss patients.
“We are excited about the results of our preliminary studies,” said researcher and hair transplant surgeon, Dr. Jerry Cooley. “By combining the MatriStem with existing follicle components, it appears that we are able to achieve true hair regeneration. Further research will help us to refine this process to make it a consistent, reproducible technique. It may be especially well suited for those who have run out of traditional hair for transplantation.”
The MatriStem MicroMatrix powder is traditionally intended for diabetic ulcers, second degree burns and surgical wounds, but Dr Cooley and Dr Gary Hitzig of New York claim it can also help regenerate hair in the donor and recipient regions of hair transplant patients.
“We’ve made amazing breakthroughs using MatriStem as a hair cloning tool,” Dr. Hitzig said. “We’ve been able to multiply the number of hair follicles growing in the recipient area, and as an added benefit are seeing faster hair growth. This new hair cloning technique also makes hair transplantation surgery less invasive.”
MatriStem promotes healing and tissue growth by triggering new blood vessel formation at the wound site, and Hitzig and Cooley say it also allows the body to regenerate the original tissue, complete with hair follicles.
However, hair restoration surgeon Dr Alan Bauman says that while he is optimistic about hair cloning, it’s an area that is still in the early stages of research and devlopment.
“I’m disappointed by the slow progress in this area of research,” Bauman said. “If you are waiting around for hair cloning, that’s a huge long-shot bet and each month that goes by, more and more hair loss is happening.”
Research may still be in the early stages, but there are treatments already available to men and women that can stabilise hair loss and generate regrowth. Propecia and minoxidil are clinically proven and MHRA-licensed for the treatment of hair loss, and are contributing to a growing number of hair loss success stories. However, they cannot re-awaken dormant or scarred hair follicles, which is where the new hair cloning technique may eventually prove advantageous.
To find out more about hair loss and the current treatments available, contact The Belgravia Centre on 020 7730 6666, or send an email. Alternatively, for a free diagnosis, simply complete the online diagnostic form for access to expert recommendations for your particular condition and stage of hair loss.